HIGHLIGHTS
- who: Nanako Hata from the DepartmentOkayama University have published the Article: ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer, in the Journal: Scientific Reports Scientific Reports
- what: The authors aimed to identify whether the ADAR1 expression can be a predictive biomarker of remnant liver recurrence after hepatic metastasectomy (Fig 1c). Interestingly, this study showed that patients with CRC who had poor prognosis had a high ADAR1 expression. This study had an extremely important finding. This study examined 83 cases of liver metastases resected from 36 patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.